STUDY OBJECTIVES:Insomnia and depressive disorders are significant health problems in the elderly. Persistent insomnia is a risk factor for the development of new-onset and recurrent major depressive disorder (MDD). Less clear is whether persistent insomnia may perpetuate MDD andlor dysthymia. The present longitudinal study examines the relationship of insomnia to the continuation of depression in the context of an intervention study in elderly subjects. DESIGN: Data were drawn from Project IMPACT, a multisite intervention study, which enrolled 1801 elderly patients with MDD and/or dysthymia. In the current study, subjects were assigned to an insomnia-status group (Persistent, Intermediate, and No Insomnia) based on insomnia scores at both baseline and 3-month time points. Logistic regressions were conducted to determine whether Persistent Insomnia was prospectively associated with increased risk of remaining depressed and/or achieving a less than 50% clinical improvement at 6 and at 12 months compared with the No Insomnia reference group. The Intermediate Insomnia group was compared with the other 2 groups to determine whether a dose-response relationship existed between insomnia type and subsequent depression. SETTING:Eighteen primary clinics in 5 states. PARTICIPANTS: Older adults (60+) with depression. MEASUREMENTS AND RESULTS: Overall, patients with persistent insomnia were 1.8 to 3.5 times more likely to remain depressed, compared with patients with no insomnia. The findings were more robust in patients receiving usual care for depression than in patients receiving enhanced care. Findings were also more robust in subjects who had MDD as opposed to those with dysthymia alone. CONCLUSIONS: These findings suggest that, in addition to being a risk factor for a depressive episode, persistent insomnia may serve to perpetuate the illness in some elderly patients and especially in those receiving standard care for depression in primary care settings. Enhanced depression care may partially mitigate the perpetuating effects of insomnia on depression.
RCT Entities:
STUDY OBJECTIVES:Insomnia and depressive disorders are significant health problems in the elderly. Persistent insomnia is a risk factor for the development of new-onset and recurrent major depressive disorder (MDD). Less clear is whether persistent insomnia may perpetuate MDD andlor dysthymia. The present longitudinal study examines the relationship of insomnia to the continuation of depression in the context of an intervention study in elderly subjects. DESIGN: Data were drawn from Project IMPACT, a multisite intervention study, which enrolled 1801 elderly patients with MDD and/or dysthymia. In the current study, subjects were assigned to an insomnia-status group (Persistent, Intermediate, and No Insomnia) based on insomnia scores at both baseline and 3-month time points. Logistic regressions were conducted to determine whether Persistent Insomnia was prospectively associated with increased risk of remaining depressed and/or achieving a less than 50% clinical improvement at 6 and at 12 months compared with the No Insomnia reference group. The Intermediate Insomnia group was compared with the other 2 groups to determine whether a dose-response relationship existed between insomnia type and subsequent depression. SETTING: Eighteen primary clinics in 5 states. PARTICIPANTS: Older adults (60+) with depression. MEASUREMENTS AND RESULTS: Overall, patients with persistent insomnia were 1.8 to 3.5 times more likely to remain depressed, compared with patients with no insomnia. The findings were more robust in patients receiving usual care for depression than in patients receiving enhanced care. Findings were also more robust in subjects who had MDD as opposed to those with dysthymia alone. CONCLUSIONS: These findings suggest that, in addition to being a risk factor for a depressive episode, persistent insomnia may serve to perpetuate the illness in some elderly patients and especially in those receiving standard care for depression in primary care settings. Enhanced depression care may partially mitigate the perpetuating effects of insomnia on depression.
Authors: Rachel Manber; A John Rush; Michael E Thase; Bruce Amow; Dan Klein; Madhukar H Trivedi; Susan G Korenstein; John C Markowitz; David L Dunner; Melvin Munsaka; Fran E Borian; B Keller Journal: Sleep Date: 2003-03-15 Impact factor: 5.849
Authors: Jürgen Unützer; Wayne Katon; Christopher M Callahan; John W Williams; Enid Hunkeler; Linda Harpole; Marc Hoffing; Richard D Della Penna; Polly Hitchcock Noël; Elizabeth H B Lin; Patricia A Areán; Mark T Hegel; Lingqi Tang; Thomas R Belin; Sabine Oishi; Christopher Langston Journal: JAMA Date: 2002-12-11 Impact factor: 56.272
Authors: J Unützer; W Katon; J W Williams; C M Callahan; L Harpole; E M Hunkeler; M Hoffing; P Arean; M T Hegel; M Schoenbaum; S M Oishi; C A Langston Journal: Med Care Date: 2001-08 Impact factor: 2.983
Authors: Jeffrey M Lyness; Eric D Caine; Deborah A King; Yeates Conwell; Paul R Duberstein; Christopher Cox Journal: Am J Geriatr Psychiatry Date: 2002 May-Jun Impact factor: 4.105
Authors: Jennifer L Martin; Lavinia Fiorentino; Stella Jouldjian; Karen R Josephson; Cathy A Alessi Journal: J Am Geriatr Soc Date: 2010-05 Impact factor: 5.562
Authors: Anita R Peoples; Sheila N Garland; Wilfred R Pigeon; Michael L Perlis; Julie Rya Wolf; Kathi L Heffner; Karen M Mustian; Charles E Heckler; Luke J Peppone; Charles S Kamen; Gary R Morrow; Joseph A Roscoe Journal: J Clin Sleep Med Date: 2019-01-15 Impact factor: 4.062
Authors: Eun Lee; Hyong Jin Cho; Richard Olmstead; Myron J Levin; Michael N Oxman; Michael R Irwin Journal: Sleep Date: 2013-11-01 Impact factor: 5.849
Authors: Leslie M Swanson; Edward D Huntley; Holli Bertram; Ann Mooney; Richard Dopp; Robert Hoffmann; Roseanne Armitage; J Todd Arnedt Journal: Behav Sleep Med Date: 2016-08-05 Impact factor: 2.964